Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Select Pharmaceuticals Portfolio

+ Add to Watchlist

FPHAX:US

23.82 USD 0.21 0.89%

As of 09:29:30 ET on 03/27/2015.

Snapshot for Fidelity Select Pharmaceuticals Portfolio (FPHAX)

Year To Date: +11.41% 3-Month: +10.69% 3-Year: +27.73% 52-Week Range: 17.81 - 24.41
1-Month: +3.21% 1-Year: +28.76% 5-Year: +22.81% Beta vs MXWO: 0.90

Mutual Fund Chart for FPHAX

No chart data available.
  • FPHAX:US 23.82
  • 1M
  • 1Y
Interactive FPHAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FPHAX

Fidelity Select Pharmaceuticals Portfolio is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types.

Inception Date: 06-18-2001 Telephone: 1-800-544-6666
Managers: ASHER ANOLIC
Web Site: www.fidelity.com

Fundamentals for FPHAX

NAV (on 2015-03-27) 23.82
Assets (M) (on 2015-02-27) 1,892.74
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FPHAX

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-12-19) 0.09
Dividend Yield (ttm) 9.26

Fees & Expenses for FPHAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 0.00
Expense Ratio 0.81

Top Fund Holdings for FPHAX

Filing Date: 01/31/2015
Name Position Value % of Total
Actavis plc 556,307 148,278,068 8.370%
Sanofi 2,984,222 137,542,792 7.764%
Johnson & Johnson 1,194,400 119,607,216 6.751%
Bristol-Myers Squibb Co 1,720,810 103,713,219 5.854%
Novartis AG 788,098 76,760,745 4.333%
Teva Pharmaceutical Industries 1,289,689 73,331,717 4.139%
Novo Nordisk A/S 1,635,400 72,873,424 4.113%
Allergan Inc/United States 284,700 62,423,322 3.524%
Mallinckrodt PLC 532,600 56,450,274 3.186%
Perrigo Co PLC 370,452 56,212,386 3.173%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil